Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Tedroff

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Neuropharmacology|October 18, 2002
PNU-96391A (OSU6162) antagonizes the development of behavioral sensitization induced by dopamine agonists in a rat model for Parkinson's diseaseN F Nichols, M G Cimini, J V Haas, et al.
Nuclear Medicine and Biology|August 1, 1997
Synthesis of [11C-methyl]-(-)-OSU6162, its regional brain distribution and some pharmacological effects of (-)-OSU6162 on the dopaminergic system studied in the rhesus monkey by positron emission tomographyH Neu, P Hartvig, R Torstenson, et al.
Synapse (New York, N.Y.)|March 28, 1998
Effects of the substituted (S)-3-phenylpiperidine (-)-OSU6162 on PET measurements in subhuman primates: evidence for tone-dependent normalization of striatal dopaminergic activityJ Tedroff, R Torstenson, P Hartvig, et al.
Journal of Neural Transmission. General Section|January 1, 1993
Positron emission tomographic studies on aromatic L-amino acid decarboxylase activity in vivo for L-dopa and 5-hydroxy-L-tryptophan in the monkey brainP Hartvig, J Tedroff, K J Lindner, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 1, 1995
Neurological Wilson's disease studied with magnetic resonance imaging and with positron emission tomography using dopaminergic markersK Westermark, J Tedroff, K A Thuomas, et al.
Acta Neurologica Scandinavica|January 1, 1990
Striatal kinetics of [11C]-(+)-nomifensine and 6-[18F]fluoro-L-dopa in Parkinson's disease measured with positron emission tomographyJ Tedroff, S M Aquilonius, A Laihinen, et al.
The Japanese Journal of Psychiatry and Neurology|June 1, 1991
Tetrahydrobiopterin and dopamine releaseY Watanabe, N Mataga, K Imamura, et al.
Archives of Toxicology|January 1, 1992
Manganese induced brain lesions in Macaca fascicularis as revealed by positron emission tomography and magnetic resonance imagingH Eriksson, J Tedroff, K A Thuomas, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 2, 2020
(3<i>S</i>)-3-(2,3-difluorophenyl)-3-methoxypyrrolidine (IRL752) -a Novel Cortical-Preferring Catecholamine Transmission- and Cognition-Promoting AgentS Hjorth, S Waters, N Waters, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Neuropharmacology|October 18, 2002
PNU-96391A (OSU6162) antagonizes the development of behavioral sensitization induced by dopamine agonists in a rat model for Parkinson's diseaseN F Nichols, M G Cimini, J V Haas, et al.
Nuclear Medicine and Biology|August 1, 1997
Synthesis of [11C-methyl]-(-)-OSU6162, its regional brain distribution and some pharmacological effects of (-)-OSU6162 on the dopaminergic system studied in the rhesus monkey by positron emission tomographyH Neu, P Hartvig, R Torstenson, et al.
Synapse (New York, N.Y.)|March 28, 1998
Effects of the substituted (S)-3-phenylpiperidine (-)-OSU6162 on PET measurements in subhuman primates: evidence for tone-dependent normalization of striatal dopaminergic activityJ Tedroff, R Torstenson, P Hartvig, et al.
Journal of Neural Transmission. General Section|January 1, 1993
Positron emission tomographic studies on aromatic L-amino acid decarboxylase activity in vivo for L-dopa and 5-hydroxy-L-tryptophan in the monkey brainP Hartvig, J Tedroff, K J Lindner, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 1, 1995
Neurological Wilson's disease studied with magnetic resonance imaging and with positron emission tomography using dopaminergic markersK Westermark, J Tedroff, K A Thuomas, et al.
Acta Neurologica Scandinavica|January 1, 1990
Striatal kinetics of [11C]-(+)-nomifensine and 6-[18F]fluoro-L-dopa in Parkinson's disease measured with positron emission tomographyJ Tedroff, S M Aquilonius, A Laihinen, et al.
The Japanese Journal of Psychiatry and Neurology|June 1, 1991
Tetrahydrobiopterin and dopamine releaseY Watanabe, N Mataga, K Imamura, et al.
Archives of Toxicology|January 1, 1992
Manganese induced brain lesions in Macaca fascicularis as revealed by positron emission tomography and magnetic resonance imagingH Eriksson, J Tedroff, K A Thuomas, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 2, 2020
(3<i>S</i>)-3-(2,3-difluorophenyl)-3-methoxypyrrolidine (IRL752) -a Novel Cortical-Preferring Catecholamine Transmission- and Cognition-Promoting AgentS Hjorth, S Waters, N Waters, et al.
Pageof 5